1. Home
  2. BZUN vs NTHI Comparison

BZUN vs NTHI Comparison

Compare BZUN & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.78

Market Cap

159.3M

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.49

Market Cap

139.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
NTHI
Founded
2007
2008
Country
China
United States
Employees
6762
5
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
139.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BZUN
NTHI
Price
$2.78
$4.49
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
277.8K
85.8K
Earning Date
05-20-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.89
N/A
Revenue Next Year
$6.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$3.20
52 Week High
$4.88
$12.99

Technical Indicators

Market Signals
Indicator
BZUN
NTHI
Relative Strength Index (RSI) 54.99 44.72
Support Level $2.62 $4.17
Resistance Level $2.82 $5.78
Average True Range (ATR) 0.13 0.53
MACD 0.01 0.02
Stochastic Oscillator 52.44 24.57

Price Performance

Historical Comparison
BZUN
NTHI

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: